InvestorsHub Logo
Followers 5
Posts 566
Boards Moderated 0
Alias Born 04/25/2013

Re: drugmanrx post# 1957

Friday, 12/07/2018 7:42:50 AM

Friday, December 07, 2018 7:42:50 AM

Post# of 2104
These trials are difficult to design because are the first of its kind. The data was really good. Emricasan has shown that it works. P2 is done to get on idea on dosage and the subgroups of patient population that it works. It did that. Moving to p3